急性B型主动脉夹层胸主动脉腔内修复术时机的影响
基于日本成人心血管外科数据库,回顾性分析680例急性及亚急性B型主动脉夹层行胸主动脉腔内修复术(TEVAR)的患者,按症状出现至手术时间分为超急性期(24小时内,295例)、急性期(24小时至14天,97例)和亚急性期(14天至6周,288例)。超急性期患者破裂、灌注不良、手术死亡及严重并发症均更常见,而急性期与亚急性期在手术死亡和严重并发症上无显著差异。
要点
- 超急性期TEVAR患者破裂(41.0%)、灌注不良(17.3%)、手术死亡(11.9%)及严重并发症(32.5%)均高于急性期和亚急性期。
- 急性期与亚急性期TEVAR在手术死亡(0% vs 1.7%,p=0.191)和严重并发症(10.3% vs 8.3%,p=0.553)上无显著差异。
- 症状出现24小时内行TEVAR与更差结局相关,而24小时至14天与14天至6周相比不增加围术期并发症风险。
核心结论
- 症状出现24小时内行TEVAR与更差结局相关,但24小时至14天与14天至6周相比不增加围术期并发症风险。
研究设计与样本
- 回顾性分析日本成人心血管外科数据库2008年1月至2013年1月间680例因急性及亚急性B型主动脉夹层行TEVAR的患者。
主要发现
- 超急性期(24小时内,295例)破裂发生率41.0%(121/295),急性期(24小时至14天,97例)7.2%(7/97),亚急性期(14天至6周,288例)4.2%(12/288),p<0.001。
- 超急性期灌注不良发生率17.3%(51/295),急性期8.3%(8/97),亚急性期5.6%(16/288),p<0.001。
- 超急性期手术死亡率11.9%(35/295),急性期0%(0/97),亚急性期1.7%(5/288),p<0.001。
- 超急性期严重并发症(包括主动脉夹层)发生率32.5%(96/295),急性期10.3%(10/97),亚急性期8.3%(24/288),p<0.001。
- 急性期与亚急性期手术死亡率比较p=0.191,严重并发症比较p=0.553,均无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to analyze the influence of the timing of intervention from presentation of symptoms to thoracic endovascular aortic repair (TEVAR) and its relation to major complications. Data were collected from the Japan Adult Cardiovascular Surgery Database. METHODS: We retrospectively analyzed the data of 680 patients who underwent TEVAR for acute and subacute type B dissection between January 2008 and January 2013. RESULTS: Thoracic endovascular aortic repair for type B dissection was performed in 680 patients: 295 repairs were performed within 24 hours of presentation of symptoms (hyperacute); 97 between 24 hours and 14 days (acute); and 288 between 14 days and 6 weeks (subacute). Hyperacute patients more frequently had immediate life-threatening complications from type B dissection such as rupture or malperfusion than did acute or subacute patients (41.0% [121 of 295] versus 7.2% [7 of 97] versus 4.2% [12 of 288]; p < 0.001; and 17.3% [51 of 295] versus 8.3% [8 of 97] versus 5.6% [16 of 288]; p < 0.001, respectively). Operative mortality and severe complications including aortic dissection were more common among hyperacute patients (11.9% [35 of 295] versus 0% [0 of 97] versus 1.7% [5 of 288]; p < 0.001; and 32.5% [96 of 295] versus 10.3% [10 of 97] versus 8.3% [24 of 288]; p < 0.001, respectively) and did not differ significantly between acute and subacute patients (p = 0.191 and p = 0.553, respectively). CONCLUSIONS: Although TEVAR performed for aortic dissection within 24 hours of presentation of symptoms was associated with worse outcomes, TEVAR performed between 24 hours and 14 days, as compared with TEVAR between 14 days and 6 weeks, does not appear to increase the risk of perioperative complications.
引用
- Miyairi T, Miyata H, Chiba K, et al. Influence of Timing After Thoracic Endovascular Aortic Repair for Acute Type B Aortic Dissection. Ann Thorac Surg. 2017. PMID: 29277670. doi:10.1016/j.athoracsur.2017.11.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。